1) Successfully developed ART352-L, a liposomal formulation of recombinant human WNT3A protein, that is applied ex vivo, to harvested autologous bone graft (autograft) to enhance the osteogenic ...

Las reuniones de la CFAOC están organizadas por la Oficina del Contralor del Estado. A continuación, se incluye una copia de la agenda publicada en https://www.sco ...

have the ability to divide and create an identical copy of themselves, a process called self-renewal; and can also divide to form cells that mature into cells that make up every type of tissue and ...

There is no shortage of myths and misconceptions when it comes to stem cell research and regenerative medicine. Here we address the most common concerns. If you have more questions that aren’t ...

Retinal degeneration represents a group of blinding diseases that are increasingly impacting the health and well being of Californians. It is estimated that by 2020, over 450,000 Californians will ...

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and ...

San Francisco, CA – California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) today approved $150 million in new funding to help move promising stem cell-based therapies ...

Untreated cartilage defects often lead to joint pain and degeneration over time, often requiring joint replacement. The proposed candidate is a universal cell therapy designed to generate new ...

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...

Many stem cell clinics, both in the U.S. and in other countries, advertise cures for a price. Understand the concerns over stem cell tourism and what CIRM is doing to bring real cures to patients who ...

Deborah K. Armstrong Johns Hopkins University Ovarian, Breast Cancer and Gynecologic Cancer Clinical Trials; Genetics of Familial Breast and Ovarian Cancer ...

Get the latest CIRM news, meetings and funding opportunities delivered straight to your inbox.